Key Takeaways
- Unilever agreed to acquire Grüns for approximately $1.2 billion in April 2026.
- Grüns surpassed $300M in annual revenue and 1M+ customers in under two years.
- The deal confirms major FMCG groups now see greens as a long-term strategic category.
- The Future Nutra Foundation is launching to provide independent supplement testing, signaling growing consumer demand for verification.
- Independent brands still have room to compete, but the window for undifferentiated players is closing fast.
In under three years, Grüns built one of the fastest-growing supplement brands in the United States. When Unilever signs a $1.2 billion check to acquire it in April 2026, the signal is impossible to ignore: greens aren't a niche anymore. They're a strategic category that the world's largest consumer goods groups want to own.
Grüns in Two Years: Numbers That Reframe the Market
Founded in 2023, Grüns built its success on a straightforward insight: make daily greens consumption as easy as eating a gummy bear. Instead of powders that require scooping, mixing, and tolerating a grassy taste, Grüns packaged its greens formula into a chewable format that dramatically lowered the barrier to daily compliance.
The results were extraordinary. By the time Unilever announced the deal, Grüns had crossed $300 million in annual recurring revenue and acquired more than 1 million active customers. Most supplement brands take five to ten years to reach that revenue threshold. Grüns did it in less than 24 months.
That velocity is essentially unprecedented in this category. For Unilever, paying a significant premium wasn't a bet. It was a calculated strategic move backed by proven consumer traction.
Why FMCG Giants Are Moving Into Greens Now
Unilever isn't new to wellness. The group already owns Liquid I.V., OLLY, and other health brands. But this acquisition is different: it's a deliberate entry into the specific greens and super-greens subcategory, one of the fastest-growing segments in the supplement industry heading into 2026.
According to data from VitaQuest (2026), green supplement formulas and phytonutrient blends rank among the highest-growth segments across the entire dietary supplement market. The demand is driven by structural consumer behaviors, not short-term trends:
- The vegetable deficit: a majority of Western consumers don't hit their recommended daily vegetable intake, and greens supplements are positioned as nutritional insurance.
- Format commodification: gummies have normalized supplementation for audiences who rejected powders due to taste, prep time, and texture issues.
- Post-pandemic health consciousness: consumers have embedded preventive nutrition into long-term behavioral routines, not just wellness phases.
Unilever's timing isn't coincidental. According to NutraIngredients' Q1 2026 M&A report, the first quarter of 2026 recorded higher M&A activity in the supplement sector than any Q1 in the past five years. Capital is actively racing to position in this category before it's fully consolidated.
What This Deal Changes for Independent Brands
FMCG consolidation in supplements has direct implications for brands that haven't yet been acquired. And they're not all negative.
On one hand, Unilever's presence in greens will accelerate the category's normalization. Grüns will gain access to Unilever's global distribution network, retail relationships, and R&D resources to develop additional SKUs. That expands the total addressable market, not just one brand's slice of it.
On the other hand, independent brands will now compete against a player with near-unlimited marketing, distribution, and product development resources. Differentiation is no longer optional.
Viable differentiation axes for independent brands in 2026:
- Formulation transparency: major groups often rely on proprietary blend opacity. Independent brands can build on full ingredient transparency, clinical dosing visibility, and direct sourcing communication.
- Niche targeting: a greens formula built specifically for endurance athletes, pregnant women, or older adults is far more defensible against a generalist player like Unilever-Grüns.
- Independent verification: this is where another market signal becomes critical.
The Future Nutra Foundation: A Signal on Consumer Demand for Verification
In the same period, the Future Nutra Foundation, a new nonprofit, announced its launch with a mandate to provide independent supplement testing accessible to mainstream consumers. This isn't a minor development.
It reflects a growing tension in the industry: consumers are buying supplements at record rates, but their trust in brand claims remains fragile. Certifications like NSF, Informed Sport, and USP exist but remain largely opaque to general audiences. The Future Nutra Foundation is positioning itself to bridge that gap with more direct-to-consumer communication about what's actually in the products they're taking.
For brands that genuinely invest in formulation quality, this creates a real opportunity. Being independently verified is going to become a competitive advantage, especially against large-group brands where marketing budgets can outpace product substance across the fastest-growing supplement categories.
Market Takeaways Worth Acting On
A few structural conclusions emerge clearly from this acquisition:
1. Nine-figure supplement exits are happening more frequently. Grüns isn't an isolated case. Q1 2026 saw multiple major transactions in the sector according to NutraIngredients. Venture capital and growth funds have taken note. That attracts more capital into the category, raising both the opportunity ceiling and the competitive floor.
2. Format matters as much as formula. Grüns didn't win because its greens blend is biochemically superior. It won because the gummy format solved a real behavioral compliance problem. Brands that focus exclusively on formulation while ignoring the product experience are leaving a major acquisition lever on the table.
3. FMCG maturation compresses the timing window. The more major groups enter a category, the harder it becomes for independents to grow organically. Greens brands without a defensible advantage have roughly a 12-to-24-month window to build one before consolidation reshapes supplement distribution and makes market conditions structurally harder to navigate.
The Unilever-Grüns deal is a clear signal. Greens are no longer an emerging market. They're a consolidating one. The question for every independent player is simple: what's your advantage that holds up against a competitor with a billion-dollar budget?